Skip to main content
Brett McGettigan
( out of 28 reviews )

Brett McGettigan, MD, PhD

Languages spoken: English, Italian, Spanish

Clinical Locations

Primary Location

Farmington Health Center

Gastroenterology
165 N. University Ave.
Farmington , UT 84025

Farmington Health Center

General Endoscopy
165 N. University Ave.
Farmington , UT 84025

Huntsman Cancer Institute - Cancer Hospital North

1K, Endoscopy
1950 Circle of Hope
Salt Lake City , UT 84112

Specialties

Board Certification

American Board of Internal Medicine (Internal Medicine)

Patient Rating

4.4 /5
( out of 28 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


Board Certification and Academic Information

Academic Departments Internal Medicine -Assistant Professor (Clinical)
Academic Divisions Gastroenterology
Board Certification
American Board of Internal Medicine (Internal Medicine)

Education history

Fellowship Gastroenterology and Hepatology - Mayo Clinic Fellow
Residency Internal Medicine - LAC+USC Medical Center Resident
Doctoral Training Immunology - University of Colorado School of Medicine Ph.D.
Professional Medical Medical Scientist Training Program - University of Colorado School of Medicine M.D.
Undergraduate Biochemistry - University of Utah B.S.

Selected Publications

Journal Article

  1. Wolf AB, Ryerson LZ, Pandey K, McGettigan BM, Vollmer T, Corboy JR, Alvarez E (2019). Rituximab-induced serum sickness in multiple sclerosis patients. Mult Scler Relat Disord, 36, 101402.
  2. McGettigan B, McMahan R, Orlicky D, Burchill M, Danhorn T, Francis P, Cheng LL, Golden-Mason L, Jakubzick CV, Rosen HR (2019). Dietary Lipids Differentially Shape Nonalcoholic Steatohepatitis Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages. Hepatology, 70(1), 67-83.
  3. McGettigan BM, McMahan RH, Luo Y, Wang XX, Orlicky DJ, Porsche C, Levi M, Rosen HR (2016). Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease. J Biol Chem, 291(44), 23058-23067.
  4. Morton JJ, Bird G, Keysar SB, Astling DP, Lyons TR, Anderson RT, Glogowska MJ, Estes P, Eagles JR, Le PN, Gan G, McGettigan B, Fernandez P, Padilla-Just N, Varella-Garcia M, Song JI, Bowles DW, Schedin P, Tan AC, Roop DR, Wang XJ, Refaeli Y, Jimeno A (2015). XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer. Oncogene, 35(3), 290-300.
  5. Delker DA, McGettigan BM, Kanth P, Pop S, Neklason DW, Bronner MP, Burt RW, Hagedorn CH (2014). RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers. PLoS One, 9(2), e88367.

Review

  1. McGettigan B, Hernandez-Tejero M, Malhi H, Shah V (2025). Immune Dysfunction and Infection Risk in Advanced Liver Disease. [Review]. Gastroenterology, 168(6), 1085-1100.

Editorial

  1. McGettigan BM (2025). Unlocking immunity’s memory: Epigenetic keys to HBV control. 82(3), 547-548.
  2. McGettigan BM, A Osna N (2024). Functional humoral immunity is crucial to outcomes in severe alcohol-associated hepatitis. Hepatology, 82(1), 19-21.
  3. McGettigan BM, Shah VH (2024). Every sheriff needs a deputy: Targeting non-parenchymal cells to treat hepatic fibrosis. J Hepatol, 81(1), 20-22.